• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Myocardial Infarction (1969)
Event Date 09/01/2017
Event Type  Injury  
Manufacturer Narrative
A supplemental medwatch report will be submitted upon completion of the investigation.
 
Event Description
A fresenius regional equipment specialist (res) was called onsite to repair a 2008k hemodialysis (hd) machine with ultrafiltration (uf) pump out of specification.It was reported a hemodialysis (hd) patient coded while receiving treatment on the machine.The res recalibrated the uf pump to resolve the issue.The machine was returned to service.Follow-up was made with the facility registered nurse (rn), who stated she was unwilling to disclose any patient information due to patient privacy/confidentiality.The rn stated the machine did not have any issues during set-up and that the machine did not alarm at the time the patient expired.The rn stated the facility used fresenius dialyzers, bloodlines, acid concentrate and bicarb concentrate delivered via jugs.The catalog and lot numbers of the fresenius products were unknown.No samples were obtained to be returned for evaluation.Although requested, no further patient specific or event related details were made available.
 
Manufacturer Narrative
Corrected (b)(4).Conclusion: a temporal relationship exists between the patient¿s reported cardiac arrest during a hd treatment and the fresenius 2008-k machine.Although there is an allegation against the fresenius 2008-k machine pulling too much fluid during treatment, any causality between the 2008-k machine or any fresenius products and the adverse event of cardiac arrest cannot be determined based on the lack of information provided.Additional information related to the patient¿s demographics, treatment data, medical interventions and hospitalization is needed to determine potential causality.A supplemental medwatch report will be submitted upon completion of the investigation.
 
Event Description
Information in the complaint file was reviewed by a post market surveillance clinician.On 09/01/2017 it was reported by a regional equipment specialist (res) that a 2008k machine ultrafiltration (uf) pump was not removing the proper amount of fluid during a hemodialysis (hd) treatment while the patient was hospitalized.Based on the information captured in the file this patient with end stage renal disease (esrd) on hd for renal replacement therapy (rrt) ¿coded¿ while receiving treatment on (b)(6) 2017 (time, patient/treatment data, vital signs and hospital course unknown).During a follow up call to the hemodialysis registered nurse (hdrn) on 09/28/2017 it was reported ¿the machine did not alarm at the time the patient coded,¿ (time unknown) nor did the machine have any issues during set-up.The hdrn additionally stated that she was unwilling to disclose any patient information.On (b)(6) 2017 the machine was taken out-of-service post event to perform functional testing.During the functional testing the machine encountered an uf pump error once during a one (1) hour period of testing.Machine testing revealed the machine was removing 25 ml over the entered uf amount 1000 ml, or 15 ml greater than maximum allowable error limit.Uf pump was recalibrated and returned to service (date unknown).
 
Manufacturer Narrative
The device was not returned to the manufacturer for physical evaluation, and the lot number was not able to be obtained to date.Distribution records were reviewed to identify potential lots of this product shipped to the customer over the past 3 months.A search on the sap system of the lots delivered to the patient was conducted, with a time frame of three months before of the event date and no information was found related to possible lot number from product fmc bloodline set.A device history records (dhr) review was not performed since the lot number is unknown and no information was found on the sap system from this customer related a possible lot number from product fmc bloodline set.
 
Event Description
Information in the complaint file was reviewed by a post market surveillance clinician.On 09/01/2017 it was reported by a regional equipment specialist (res) that a 2008k machine ultrafiltration (uf) pump was not removing the proper amount of fluid during a hemodialysis (hd) treatment while the patient was hospitalized.Based on the information captured in the file this patient with end stage renal disease (esrd) on hd for renal replacement therapy (rrt) ¿coded¿ while receiving treatment on (b)(6) 2017 (time, patient/treatment data, vital signs and hospital course unknown).During a follow up call to the hemodialysis registered nurse (hdrn) on 09/28/2017 it was reported ¿the machine did not alarm at the time the patient coded,¿ (time unknown) nor did the machine have any issues during set-up.The hdrn additionally stated that she was unwilling to disclose any patient information.On (b)(6) 2017, the machine was taken out-of-service post event to perform functional testing.During the functional testing the machine encountered an uf pump error once during a one (1) hour period of testing.Machine testing revealed the machine was removing 25 ml over the entered uf amount 1000 ml, or 15 ml greater than maximum allowable error limit.Uf pump was recalibrated and returned to service (date unknown).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FMC BLOODLINE
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX   88780
Manufacturer Contact
thomas c. johnson
920 winter st.
waltham, MA 02451
7816999499
MDR Report Key6904992
MDR Text Key87794367
Report Number8030665-2017-00785
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup,Followup
Report Date 10/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Device Age MO
Date Manufacturer Received10/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-